87 related articles for article (PubMed ID: 1922899)
1. [Cytological history of 101 patients with invasive cancer of the uterine cervix].
Vincenzoni C; Mariani L; Vocaturo G; Lombardi A; Iacovelli A
Minerva Ginecol; 1991 Jun; 43(6):273-7. PubMed ID: 1922899
[TBL] [Abstract][Full Text] [Related]
2. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic cytological investigation for cervical cancer in relation to stage at diagnosis: a study of 420 women in Denmark.
Olesen F
J R Coll Gen Pract; 1988 Aug; 38(313):356-9. PubMed ID: 3256647
[TBL] [Abstract][Full Text] [Related]
4. Screening history of women in Malmö with invasive cervical cancer.
Lindqvist PG; Hellsten C; Rippe A
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
[TBL] [Abstract][Full Text] [Related]
5. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
6. [Cytological history of cases of invasive cervical cancer diagnosed in France in 2006].
Boulanger JC; Fauvet R; Urrutiaguer S; Drean Y; Sevestre H; Ganry O; Bergeron C; Gondry J
Gynecol Obstet Fertil; 2007 Sep; 35(9):764-71. PubMed ID: 17765001
[TBL] [Abstract][Full Text] [Related]
7. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
8. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
9. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
10. Review of the screening history of Alberta women with invasive cervical cancer.
Stuart GC; McGregor SE; Duggan MA; Nation JG
CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
[TBL] [Abstract][Full Text] [Related]
11. [Value of the Pap-test in the cervical cytological screening].
Giannone R; Piacezzi C; Poli M; Bernorio R
Minerva Ginecol; 1992 Apr; 44(4):155-9. PubMed ID: 1584446
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
13. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of cervical neoplasia.
La Vecchia C
Biomed Pharmacother; 1985; 39(8):426-33. PubMed ID: 3841750
[TBL] [Abstract][Full Text] [Related]
15. [Incidence and mortality of uterine cervix cancer in Norway. When do we get organized nation-wide cytologic screening in Norway?].
Magnus K; Langmark F
Tidsskr Nor Laegeforen; 1990 May; 110(12):1557-9. PubMed ID: 2187277
[TBL] [Abstract][Full Text] [Related]
16. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
Misra JS; Gupta HP; Das V
Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
18. Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols.
Bearman DM; MacMillan JP; Creasman WT
Obstet Gynecol; 1987 Feb; 69(2):151-5. PubMed ID: 3808501
[TBL] [Abstract][Full Text] [Related]
19. Screening history of women with invasive cervical cancer in north-east Italy.
Zucchetto A; Franceschi S; Clagnan E; Serraino D; Zanier L; Franzo A;
Eur J Obstet Gynecol Reprod Biol; 2010 Oct; 152(2):200-4. PubMed ID: 20667643
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
